Trial result

Bladder Cancer Surgery Just Became a System Test

AstraZeneca’s heart drug failure raises a brutal question: how much treatment is too much treatment?

A Blood Test Will Not Fix Colorectal Screening by Itself

Radioligand Therapy Is Building Its Evidence Base. Now Build the Infrastructure.

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Desmoid Tumours Are Not Benign to the People Living With Them

Pancreatic Cancer Is Forcing Regulators to Move Faster

Early Lung Cancer Just Became a Biomarker Test of the System

Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
